ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 45 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,096,354 | +17.0% | 270,424 | +5.0% | 0.00% | 0.0% |
| Q2 2023 | $2,647,347 | +76.8% | 257,524 | +32.8% | 0.00% | – |
| Q1 2023 | $1,497,580 | +6.4% | 193,987 | +1.3% | 0.00% | – |
| Q4 2022 | $1,408,054 | +57.1% | 191,572 | +53.9% | 0.00% | – |
| Q3 2022 | $896,000 | -16.3% | 124,478 | -1.0% | 0.00% | – |
| Q2 2022 | $1,071,000 | +17.4% | 125,774 | +23.7% | 0.00% | – |
| Q1 2022 | $912,000 | -37.7% | 101,708 | -3.7% | 0.00% | – |
| Q4 2021 | $1,463,000 | +27.9% | 105,595 | -1.5% | 0.00% | – |
| Q3 2021 | $1,144,000 | +11.9% | 107,234 | -5.6% | 0.00% | – |
| Q2 2021 | $1,022,000 | +384.4% | 113,579 | +470.4% | 0.00% | – |
| Q1 2021 | $211,000 | -15.3% | 19,913 | +0.6% | 0.00% | – |
| Q4 2020 | $249,000 | +91.5% | 19,801 | +34.4% | 0.00% | – |
| Q3 2020 | $130,000 | +348.3% | 14,733 | +44.6% | 0.00% | – |
| Q1 2020 | $29,000 | -25.6% | 10,188 | 0.0% | 0.00% | – |
| Q4 2019 | $39,000 | -4.9% | 10,188 | -0.7% | 0.00% | – |
| Q3 2019 | $41,000 | -6.8% | 10,260 | -1.0% | 0.00% | – |
| Q2 2019 | $44,000 | -38.0% | 10,360 | 0.0% | 0.00% | – |
| Q1 2019 | $71,000 | – | 10,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
| Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
| GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
| Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
| Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
| COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
| Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
| Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
| Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |